Nimbus Therapeutics announced the launch of a first-in-human clinical trial for NDI-219216, its investigational Werner ...

In the phase 3 HARMONi-6 trial, ivonescimab, Akeso’s PD-1/VEGF bispecific antibody, combined with chemotherapy, demonstrated ...

Boehringer Ingelheim has announced a collaboration with Tessellate Bio, to develop a new class of targeted therapies for ...

Biosciences announced the first patient has been dosed in its Phase 2 trial of MB-105, a first-in-class CD5-targeted CAR-T ...

Medicus Pharma’s Phase 2 trial of its dissolvable microneedle patch for nodular basal cell carcinoma has expanded from 60 to ...